Arke Estudios Clínicos S.A. de C.V.

Mexico City 06700

1 studies enrolling now · 4 studies all time

What they study most

Breast Neoplasms, KRAS G12C Lung Cancer, Neoplasms, Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer (NSCLC)

Studies at this site

• A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer — Recruiting now
• A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer — Running, not enrolling
• A Study of Tiragolumab in Combination With Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin Versus Pembrolizumab Plus Pemetrexed and Carboplatin/Cisplatin in Participants With Previously Untreated Advanced Non-Squamous Non-Small Cell Lung Cancer — Completed
• Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancer — Completed